
Loading, please wait...

Loading, please wait...

The Delhi government recently announced a significant expansion of its neonatal health initiative, Mission ANMOL. This ambitious project aims to increase annual screening coverage from 1.5 lakh to 2.5 lakh infants. Consequently, the government seeks to achieve near-universal screening across all public health facilities and outreach centers. Health Minister Pankaj Kumar Singh emphasized that this scale-up facilitates early identification of metabolic, endocrine, and visible congenital conditions. Therefore, timely intervention will significantly improve long-term health outcomes for thousands of newborns in the capital.
The expanded screening protocol targets several critical conditions that require immediate postnatal attention. Specifically, the program covers congenital hypothyroidism, congenital heart defects, and hearing impairment. Additionally, a major focus remains on the early detection of retinopathy of prematurity (ROP). Because early diagnosis is vital, the government has integrated a technology-driven approach aligned with national clinical guidelines. This strategy ensures that comprehensive screening becomes a standardized practice within Delhi's public health infrastructure. Furthermore, strengthened coordination between delivery-load hospitals and neonatal intensive care units (NICUs) will minimize the risk of missing any infant before discharge.
To support this massive logistical undertaking, the government approved 148 dedicated positions. This workforce includes 60 new staff nurses and 15 optometrists. These professionals play a crucial role in sample collection, especially for critically ill or pre-term infants. Meanwhile, optometrists will focus primarily on ROP screening to prevent childhood blindness. Because transport and care coordination are essential, the additional staff will streamline the movement of infants needing specialized follow-up. This investment reflects a robust commitment to ensuring that no child is left behind in the pursuit of optimal life care.
Q1: What is the primary goal of Mission ANMOL?
The primary goal is to ensure early detection and management of congenital disorders through universal newborn screening in Delhi's public health system.
Q2: Which conditions are covered under the expanded screening program?
The program covers congenital hypothyroidism, congenital heart defects, hearing impairment, and retinopathy of prematurity (ROP).
Q3: How many infants will be covered annually under the new expansion?
The expansion aims to cover approximately 2.5 lakh infants every year, increasing from the previous capacity of 1.5 lakh.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Delhi scales Mission ANMOL to screen 2.5 lakh infants annually for congenital disorders, adding 148 staff to ensure near-universal neonatal screening covera...
6 months ago

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today

Leucine Rich Bio has introduced South Asia's first comprehensive vaginal microbiome test, BugSpeaks. By profiling microbial dysbiosis, pathogens, and antimicrobial resistance, this next-generation diagnostic platform provides clinicians with deeper insights into recurrent infections, fertility, and reproductive health.
Today

In high-risk pulmonary embolism complicated by severe anemia and active uterine bleeding, systemic thrombolysis is contraindicated. Large-bore aspiration thrombectomy provides rapid hemodynamic rescue without fibrinolysis, supported by inferior vena cava filter placement and multidisciplinary critical care.
Today

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today